¸ð½Ã´Â±Û ÇÁ·Î±×·¥ ÃÊ·ÏÁ¢¼ö »çÀüµî·Ï ¹ßÇ¥ÀÚ ¾È³» ¼ö»óÀÚ ¾È³» Çà»çÀå¾È³» ¼÷¹Ú¾È³» Ȩ

2009³âµµ Á¦ 95Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ ÃÖ¿ì¼ö³í¹®»ó ¼ö»óÀÚ·Î ¼±Á¤µÇ½ÉÀ» Áø½ÉÀ¸·Î ÃàÇϵ帳´Ï´Ù.


=== ´Ù À½ ===

ACCUVIX »ó
  • ºÐ¾ß : ¸ðüžÆÀÇÇÐ
  • ¼º¸í : ȲÇѼº (°Ç±¹ÀÇ´ë)
  • Á¦¸ñ : Increased senescence and reduced functional ability of fetal endothelial progenitor cells in pregnancies complicated by preeclampsia without intrauterine growth restriction
  • °ÔÀçÁö : American Journal of Obstetrics and Gynecology
ASTRAZENECA »ó
  • ºÐ¾ß : »ý½Ä³»ºÐºñÇÐ
  • ¼º¸í : Á¶½ÃÇö (¿¬¼¼ÀÇ´ë)
  • Á¦¸ñ : Neutrophil-to-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosis
  • °ÔÀçÁö : Fertility & Sterility
Çѱ¹¿©¼º¾Ï¿¬±¸Àç´Ü »ó
  • ºÐ¾ß : ºÎÀÎÁ¾¾çÇÐ
  • ¼º¸í : ³²ÀºÁö (¿¬¼¼ÀÇ´ë)
  • Á¦¸ñ : MicroRNA expression profiles in serous ovarian carcinoma
  • °ÔÀçÁö : Clinical Cancer Research
Bayer Schering Pharma »ó
  • ºÐ¾ß : ÀϹݺÎÀΰúÇÐ
  • ¼º¸í : Çѽ¼ö (Áß¾ÓÀÇ´ë)
  • Á¦¸ñ : Association of cyclin D1 G870A polymorphism with uterine leiomyoma in women whose body mass index values are above 25 kg/m2
  • °ÔÀçÁö : Human Reproduction